Report: Boots Entertains $10 Billion Sale Amid IPO Talks
Private equity firm Sycamore Partners and Italian entrepreneur Stefano Pessina are exploring an initial public offering for the pharmacy chain, but are also in talks with the Canadian branch of the…
Read the full articleYou might also wanna read
Superdrug's potential IPO highlights its outperformance over Boots in UK retail
Superdrug grew almost twice as fast as Boots over past four years
ft.trib.al·1mo ago
Australian pharmacy group pulls out of $10bn talks to buy Boots
Sigma Healthcare says deal for UK retailer would not meet its strategic objectives
ft.trib.al·1mo ago
Footwear brand Baldinini deploys turnaround plan backed by new shareholder
Baldinini’s recent share capital increase was backed by an undisclosed global footwear producer. The brand is targeting 40% growth and plans
Jersey Mike's IPO Filing Shows Over $50 Million in Pay to Founder's Stepson
Jersey Mike's plans to list Class A common stock on the New York Stock Exchange under the ticket symbol “JMKE,” though it is unclear when it
forbes.com·14d agoA Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.
This global medical device innovator, known for advanced breast implant systems, reported a notable insider sale in recent filings.
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Comments
Sign in to join the conversation.
No comments yet. Be the first.